Company profile: CardioGenics
1.1 - Company Overview
Company description
- Provider of sensitive diagnostic test products to the IVD market.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CardioGenics
Boston Heart Diagnostics
HQ: United States
Website
- Description: Provider of cardiovascular disease management solutions, combining proprietary lipid testing, advanced diagnostics, therapy guidelines, and patient support. Offerings include CVMap, Polygenic Risk Map, LipoMap NMR lipid panel, dried blood spot testing with 40+ assays, advanced lipid tests for risk stratification and chronic care, and a tailored lifestyle program for long-term health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boston Heart Diagnostics company profile →
EBR Systems
HQ: United States
Website
- Description: Provider of wireless cardiac pacing solutions, including the WiSE CRT System for cardiac resynchronization therapy that delivers stimulation directly to the inside of the left ventricle and is designed to overcome limitations of existing CRT systems, leveraging proprietary WiSE Technology for wireless tissue stimulation that eliminates the need for a left-ventricle lead.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EBR Systems company profile →
Vascular Therapies
HQ: United States
Website
- Description: Provider of biopharma solutions to improve vascular surgery outcomes in patients with kidney and vascular diseases, including Sirogen, a proprietary sirolimus formulation for local perivascular drug delivery, and ACCESS 2, a Phase 3 randomized clinical trial evaluating Sirogen’s effectiveness in improving AV fistula outcomes in elderly hemodialysis patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vascular Therapies company profile →
FineHeart
HQ: France
Website
- Description: Provider of France-based innovative cardiovascular medical devices, including the FLOWMAKER®, a fully implantable, wirelessly powered mechanical circulatory support device that optimizes cardiac output while preserving heart contractility. Offers ICOMS FLOWMAKER® clinical trials to evaluate safety and performance in advanced heart failure, and partners with Lauak Group to manufacture pump parts, with final assembly in-house.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FineHeart company profile →
PQ Bypass
HQ: United States
Website
- Description: Provider of minimally-invasive endovascular solutions advancing the treatment of long-segment peripheral artery disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PQ Bypass company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CardioGenics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CardioGenics
2.2 - Growth funds investing in similar companies to CardioGenics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CardioGenics
4.2 - Public trading comparable groups for CardioGenics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →